Latest Press Releases

The Role of CRISPR Libraries in Advancing Cancer Research: From Target Identification to Personalized Therapy

CRISPR-Cas9 technology has revolutionized genetic research, providing an efficient method for gene editing. CRISPR libraries , collections of guide RNAs (gRNAs) designed for large-scale genetic screens, have emerged as powerful tools in cancer ...

Philips Highest Ranked Medical Technology Company Among Clarivate Top 100 Global Innovators

March 12, 2025 - Amsterdam, the Netherlands Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has been recognized by Clarivate as the top-ranked medical technology company in the Top 100 Global ...

The Benefits of Health Insurance for Senior Citizens

Ageing is inevitable, but no one should face financial problems during medical emergencies. Senior citizens, especially, are at a higher risk of facing unique health challenges, from chronic illnesses to unexpected hospitalisations. With the ...

Embracing change: AI's Influence on Tech Careers

Change is part of life. The tech world knows this well. In the last few years, AI has changed how we work. It has changed what jobs look like. It has changed what skills we need. For tech workers in India, this shift brings both fear and hope. ...

How Much Term Insurance Coverage Do You Really Need? Here Is the Right Formula

How much life cover is enough? Should it be ₹50 lakh? ₹1 crore? Or something more like ₹5 crore? Most of us struggle to figure out the adequate life cover after deciding to buy term insurance plan and may end up under insured. ...

BioCity Biopharmaceutics Co., Ltd. Announces Clinical Collaboration to Evaluate BC3195 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Locally Advanced or Metastatic Solid Tumors

PR Newswire SHANGHAI, March 13, 2025 SHANGHAI, March 13, 2025 /PRNewswire/ -- BioCity Biopharmaceutics Co., Ltd., a clinical-stage biopharmaceutical company, today announced that it has entered into a clinical trial collaboration agreement ...

The Role of CRISPR Libraries in Advancing Cancer Research: From Target Identification to Personalized Therapy

CRISPR-Cas9 technology has revolutionized genetic research, providing an efficient method for gene editing. CRISPR libraries , collections of guide RNAs (gRNAs) designed for large-scale genetic screens, have emerged as powerful tools in cancer ...

GC Cell Initiates First Patient Dosing in Phase 1 Clinical Trial for GCC2005, a Promising T-Cell Lymphoma CD5 CAR-NK Therapy

PR Newswire YONGIN, South Korea, March 12, 2025 YONGIN, South Korea, March 12, 2025 /PRNewswire/ -- GC Cell (KRX:144510), under the leadership of CEO Sungyong Won, announced today the initiation of its domestic Phase 1 clinical trial for ...

STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), now available in the United States

PR Newswire JERSEY CITY, N.J., March 12, 2025 JERSEY CITY, N.J., March 12, 2025 /PRNewswire/ -- Celltrion today announced the U.S. launch of STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), following approval by the U.S. ...

ROZLYTREK's Market Growth Reflects Transforming Treatment for NTRK and ROS1-Positive Cancers | DelveInsight

PR Newswire LAS VEGAS, March 12, 2025 As biomarker testing and the demand for tumor-agnostic therapies rise, ROZLYTREK can potentially target a specialized yet valuable market segment. While competition from other TRK inhibitors, such as ...

New Consortium to Transform Pediatric Tonsillectomy and Adenoidectomy Care

PR Newswire SEATTLE, March 12, 2025 Consortium for Improvement of Tonsillectomies and Adenoidectomies Launches with Seattle Children's, Nemours Children's, and Children's Minnesota as Inaugural Participants SEATTLE, March 12, 2025 ...

Console & Associates P.C. Investigating Depo-Provera Injuries: Meningioma Brain Tumor Risks for Women Using Injectable Contraceptives

PR Newswire MARLTON, N.J., March 12, 2025 MARLTON, N.J., March 12, 2025 /PRNewswire/ -- A growing number of women who received Depo-Provera injections are coming forward with serious health concerns following new research linking the ...

RedHill Biopharma Advances its Groundbreaking Late-Stage Crohn's Disease Program Building on Statistically Significant Positive RHB-104 Phase 3 Results

PR Newswire RALEIGH, N.C. and TEL-AVIV, Israel, March 12, 2025 The planned innovative Phase 2 study of RHB-2041 will be the first ever clinical study in Crohn's Disease (CD) patients who are all MAP-positive, and will correlate mucosal ...

New Research from Hopelab and Born This Way Foundation Reveals Online Spaces Provide a Lifeline to LGBTQ+ Young People

PR Newswire SAN FRANCISCO, March 12, 2025 SAN FRANCISCO, March 12, 2025 /PRNewswire/ -- New research from Hopelab and Born This Way Foundation examines how LGBTQ+ young people connect to online friendships and communities to explore their ...

Vivace Therapeutics Raises $35 Million in Series D Financing to Support Clinical Development of First-in-Class Cancer Drug Targeting the Hippo Pathway

PR Newswire SAN MATEO, Calif., March 12, 2025 Financing Led by RA Capital Management with Participation from Other Existing Investors Canaan Partners and Cenova Capital VT3989 is the Only TEAD Autopalmitoylation Inhibitor for which ...

Harbour BioMed Launches Élancé Therapeutics to Advance Next-Generation Obesity Therapies

PR Newswire CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 12, 2025 - Élancé Therapeutics aims to improve current obesity treatment, specifically to increase overall body weight loss and fat mass loss, but preserve and even ...

Children's Respite Homes of America Aims to Address the Severe Lack of Children's Respite and Palliative Care Homes in the U.S.

PR Newswire SCOTTSDALE, Ariz., March 11, 2025 Only a handful of respite homes exist in America, yet nearly 1 million medically fragile children could benefit from this critical care. Now, Children's Respite Homes of America aims to address ...

Ascletis Announces Positive Topline Results of Phase Ib Studies of ASC47 Monotherapy in Australia and U.S. FDA Clearance of IND Application for ASC47 in Combination with Semaglutide

PR Newswire HONG KONG, March 11, 2025 HONG KONG, March 11, 2025 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX:1672, "Ascletis") announces encouraging pharmacokinetic and weight loss data from its ASC47 Phase Ib single subcutaneous injection ...

New Study Reveals Significant Improvements in Recovery Assessment Scores of 20,000 Patients at Discovery Behavioral Health

PR Newswire LOS ANGELES, March 11, 2025 LOS ANGELES, March 11, 2025 /PRNewswire/ -- Discovery Behavioral Health, Inc. (DBH) announced a newly published study, Changes in Recovery Assessment Scale Scores During a Treatment Episode Among ...

All-Female Surgical Team at Pittsburgh's Allegheny General Hospital Performs Cardiac Surgery in Honor of International Women's Day

PR Newswire PITTSBURGH, March 11, 2025 Students from local high school provided with bird's eye view of operating room as part of program designed to inspire careers in medicine PITTSBURGH, March 11, 2025 /PRNewswire-PRWeb/ -- In ...

American Parkinson Disease Association to Educate and Empower During Parkinson's Disease Awareness Month

PR Newswire NEW YORK, March 11, 2025 APDA helps the Parkinson's community live life to the fullest in April and year-round. With a diagnosis every six minutes, public awareness and support are crucial. NEW YORK, March 11, 2025 ...

HealthTree Foundation Launches New Mobile App to Empower Blood Cancer Patients

PR Newswire SALT LAKE CITY, March 10, 2025 HealthTree App Offers Patient Support, Education, and Research Participation in One Seamless Platform SALT LAKE CITY, March 10, 2025 /PRNewswire/ -- HealthTree Foundation, a global nonprofit ...

Kodiak Sciences Completes Enrollment in Second Registrational Trial of Tarcocimab in Patients with Diabetic Retinopathy

PR Newswire PALO ALTO, Calif., March 10, 2025 PALO ALTO, Calif., March 10, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today announced that it has completed enrollment in its GLOW2 Phase 3 clinical trial of tarcocimab tedromer ...

Protecting Women's Health: Visionary's Precision Cervical Cancer Screening Public Welfare Activity Brings Health Blessings to Women

PR Newswire TORONTO, March 10, 2025 TORONTO, March 10, 2025 /PRNewswire/ -- On March 8, 2025, the public welfare activity of "Celebrating International Women's Day and Caring for Women's Health" and the "Global Press Conference of E7 Protein ...

Healthy environment for youth stressed

PR Newswire BEIJING, March 10, 2025 BEIJING, March 10, 2025 /PRNewswire/ -- The following article was published today by China Daily. Chinese courts will further strengthen measures aimed at preventing children from committing crimes, ...

Gan & Lee Pharmaceuticals Announced First Participant Dosed in the US Phase 2 Clinical Study of Bofanglutide (GZR18) Injection for Overweight or Obesity

PR Newswire BEIJING and BRIDGEWATER, N.J., March 10, 2025 BEIJING and BRIDGEWATER, N.J., March 10, 2025 /PRNewswire/ -- Gan & Lee Pharmaceuticals (Gan & Lee, Shanghai Stock Exchange: 603087) announced that the first participant has been ...

March is Colorectal Cancer Awareness Month - Are You Up to Date on Your Screening?

PR Newswire OAKLAND, Calif., March 10, 2025 Blue Shield's Dr. Scott Flinn explains the risk factors, symptoms and tests that could save your life. OAKLAND, Calif., March 10, 2025 /PRNewswire/ -- Colorectal cancer is the second-leading ...

FDA Accepts Biologics License Application for Duchenne Muscular Dystrophy Cardiomyopathy Treatment

PR Newswire PARAMUS, N.J., March 10, 2025 PARAMUS, N.J., March 10, 2025 /PRNewswire/ -- NS Pharma, Inc. (NS Pharma), a subsidiary of Nippon Shinyaku Co., Ltd. (Nippon Shinyaku), announced today that acceptance has been received by Capricor ...

SurvivorRx Launches First-of-its-Kind Personalized Wellness Program for Cancer Survivors

PR Newswire JACKSONVILLE, Fla., March 10, 2025 The Oncologist-Founded Brand Introduces Supplements & Resources to Thrive in Life After Treatment JACKSONVILLE, Fla., March 10, 2025 /PRNewswire/ -- SurvivorRx, the first-of-its-kind ...

World's First Large-Scale, Multicenter Prospective Study in Single-Reading Mammography Confirms Lunit AI Boosts Cancer Detection

PR Newswire SEOUL, South Korea, March 10, 2025 Prospective study finds Lunit AI increases cancer detection by 13.8% in single-reader settings without raising recall rates, presenting a game-changing tool for countries relying on ...

Simple Solution Expert Brings Latest in Transforming One's Life and Reducing Stress

PR Newswire WASHINGTON, March 10, 2025 Author Raman Pathik Releases Latest Guide to Living Happier, Healthier Life WASHINGTON, March 10, 2025 /PRNewswire-PRWeb/ -- From the author who introduced the meditative technique of "Baby ...

Icotrokinra meets primary endpoint of clinical response in ulcerative colitis study and shows potential to transform the treatment paradigm for patients

PR Newswire SPRING HOUSE, Pa., March 10, 2025 Topline results also show investigational targeted oral peptide icotrokinra achieved clinical remission rates up to 30.2% at Week 12 and a favorable safety profile in Phase 2b ANTHEM-UC study ...

Alphyn Poster at American Academy of Dermatology Annual Meeting Highlights Potential of Zabalafin Hydrogel as Singular, Comprehensive Treatment for Atopic Dermatitis

PR Newswire ANNAPOLIS, Md. and ORLANDO, Fla., March 10, 2025 Phase 2a clinical program demonstrates safety and efficacy for all endpoints in AD with and without secondary infection ANNAPOLIS, Md. and ORLANDO, Fla., March 10, 2025 ...

Sigrid Therapeutics Secures U.S. Market Access for SiPore® Technology Following SHINE Prediabetes Study Success

PR Newswire STOCKHOLM, March 10, 2025 STOCKHOLM, March 10, 2025 /PRNewswire/ -- Sigrid Therapeutics (Sigrid) is excited to announce that it has secured U.S. market access for its proprietary SiPore® technology, following the success of the ...

Trevi Therapeutics Announces Positive Topline Results from the Phase 2a RIVER Trial of Haduvio in Patients with Refractory Chronic Cough

PR Newswire NEW HAVEN, Conn., March 10, 2025 Haduvio met the primary endpoint with a statistically-significant reduction (p Haduvio showed similar efficacy in patients with moderate or severe cough counts (p Haduvio is the first and ...

Latest Press Releases

Premium Press Releases »

The Role of CRISPR Libraries in Advancing Cancer Research: From Target Identification to Personalized Therapy

Philips Highest Ranked Medical Technology Company Among Clarivate Top 100 Global Innovators

The Benefits of Health Insurance for Senior Citizens

Embracing change: AI's Influence on Tech Careers

How Much Term Insurance Coverage Do You Really Need? Here Is the Right Formula

Press Releases »

BioCity Biopharmaceutics Co., Ltd. Announces Clinical Collaboration to Evaluate BC3195 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Locally Advanced or Metastatic Solid Tumors

The Role of CRISPR Libraries in Advancing Cancer Research: From Target Identification to Personalized Therapy

GC Cell Initiates First Patient Dosing in Phase 1 Clinical Trial for GCC2005, a Promising T-Cell Lymphoma CD5 CAR-NK Therapy

STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), now available in the United States

ROZLYTREK's Market Growth Reflects Transforming Treatment for NTRK and ROS1-Positive Cancers | DelveInsight

New Consortium to Transform Pediatric Tonsillectomy and Adenoidectomy Care

Console & Associates P.C. Investigating Depo-Provera Injuries: Meningioma Brain Tumor Risks for Women Using Injectable Contraceptives

RedHill Biopharma Advances its Groundbreaking Late-Stage Crohn's Disease Program Building on Statistically Significant Positive RHB-104 Phase 3 Results

New Research from Hopelab and Born This Way Foundation Reveals Online Spaces Provide a Lifeline to LGBTQ+ Young People

Vivace Therapeutics Raises $35 Million in Series D Financing to Support Clinical Development of First-in-Class Cancer Drug Targeting the Hippo Pathway

Harbour BioMed Launches Élancé Therapeutics to Advance Next-Generation Obesity Therapies

Children's Respite Homes of America Aims to Address the Severe Lack of Children's Respite and Palliative Care Homes in the U.S.

Ascletis Announces Positive Topline Results of Phase Ib Studies of ASC47 Monotherapy in Australia and U.S. FDA Clearance of IND Application for ASC47 in Combination with Semaglutide

New Study Reveals Significant Improvements in Recovery Assessment Scores of 20,000 Patients at Discovery Behavioral Health

All-Female Surgical Team at Pittsburgh's Allegheny General Hospital Performs Cardiac Surgery in Honor of International Women's Day

American Parkinson Disease Association to Educate and Empower During Parkinson's Disease Awareness Month

HealthTree Foundation Launches New Mobile App to Empower Blood Cancer Patients

Kodiak Sciences Completes Enrollment in Second Registrational Trial of Tarcocimab in Patients with Diabetic Retinopathy

Protecting Women's Health: Visionary's Precision Cervical Cancer Screening Public Welfare Activity Brings Health Blessings to Women

Healthy environment for youth stressed

Gan & Lee Pharmaceuticals Announced First Participant Dosed in the US Phase 2 Clinical Study of Bofanglutide (GZR18) Injection for Overweight or Obesity

March is Colorectal Cancer Awareness Month - Are You Up to Date on Your Screening?

FDA Accepts Biologics License Application for Duchenne Muscular Dystrophy Cardiomyopathy Treatment

SurvivorRx Launches First-of-its-Kind Personalized Wellness Program for Cancer Survivors

World's First Large-Scale, Multicenter Prospective Study in Single-Reading Mammography Confirms Lunit AI Boosts Cancer Detection

Simple Solution Expert Brings Latest in Transforming One's Life and Reducing Stress

Icotrokinra meets primary endpoint of clinical response in ulcerative colitis study and shows potential to transform the treatment paradigm for patients

Alphyn Poster at American Academy of Dermatology Annual Meeting Highlights Potential of Zabalafin Hydrogel as Singular, Comprehensive Treatment for Atopic Dermatitis

Sigrid Therapeutics Secures U.S. Market Access for SiPore® Technology Following SHINE Prediabetes Study Success

Trevi Therapeutics Announces Positive Topline Results from the Phase 2a RIVER Trial of Haduvio in Patients with Refractory Chronic Cough

Medindia Newsletters